MedTrace Logo

Severe Asthma Research Program (SARP)- San Francisco Clinical Site

NCT01718197 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 151

Last updated 2025-07-31

No results posted yet for this study

Summary

The mission of SARP is to improve the understanding of severe asthma through integrated study of its clinical and biological features and to evaluate their changes over time. The ultimate goal of these efforts is to promote better treatments for severe asthma.

Conditions

Sponsors & Collaborators

Principal Investigators

  • John V Fahy, MD, MSc · University of California, San Francisco

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-11-30
Primary Completion
2020-02-18
Completion
2021-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01718197 on ClinicalTrials.gov